当前位置:首页 - 行情中心 - 翰宇药业(300199) - 财务分析

翰宇药业

(300199)

  

流通市值:152.64亿  总市值:180.80亿
流通股本:7.46亿   总股本:8.83亿

翰宇药业(300199)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润0.70亿元,每股收益0.08元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益66607.69万元,未分配利润-177901.45万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产317064.68万元,负债250456.99万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入683,122,870.45549,442,106.79309,969,965.34590,199,011.64
营业总成本607,896,350.24407,008,743.17231,507,233.07708,040,579.18
其他经营收益
营业利润92,272,455.41160,040,053.3376,444,987.52-161,386,422.37
利润总额87,613,673.41159,960,853.0776,345,940.73-162,412,259.29
净利润69,758,073.47144,519,356.9269,439,025.34-180,091,957.93
每股收益
其他综合收益-841,191.83-323,282.97-99,383.361,864,588.58
综合收益总额68,916,881.64144,196,073.9569,339,641.98-178,227,369.35
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计565,088,980.79799,663,777.91494,618,808.48463,048,006.84
非流动资产:
非流动资产合计2,605,557,791.332,572,385,649.182,543,426,762.222,545,177,633.25
资产总计3,170,646,772.123,372,049,427.093,038,045,570.73,008,225,640.09
流动负债:
流动负债合计1,516,680,236.881,666,206,256.721,591,998,857.861,424,553,168.65
非流动负债:
非流动负债合计987,889,672.4964,600,584.4779,660,558.84986,625,959.42
负债合计2,504,569,909.282,630,806,841.122,371,659,416.72,411,179,128.07
所有者权益(或股东权益):
归属于母公司股东权益合计649,150,598.16723,772,170.75648,395,821.48578,626,837.31
股东权益合计666,076,862.84741,242,585.97666,386,154597,046,512.02
负债和股东权益合计3,170,646,772.123,372,049,427.093,038,045,570.73,008,225,640.09
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计799,866,415.7520,801,293.43202,910,272.01766,211,441.71
经营活动现金流出小计529,167,240.51363,656,725.13162,484,976.69601,505,781.16
经营活动产生的现金流量净额270,699,175.19157,144,568.340,425,295.32164,705,660.55
投资活动产生的现金流量:
投资活动现金流入小计7,780,425.684,028,964.83,746,209.951,646,205.25
投资活动现金流出小计173,272,458.8177,668,234.2134,282,205.58121,655,382.8
投资活动产生的现金流量净额-165,492,033.13-73,639,269.41-30,535,995.68-70,009,177.55
筹资活动产生的现金流量:
筹资活动现金流入小计1,107,100,971.04753,157,32070,000,0001,531,683,185.23
筹资活动现金流出小计1,189,769,767.06561,139,756.53120,077,959.581,877,160,686.72
筹资活动产生的现金流量净额-82,668,796.02192,017,563.47-50,077,959.58-345,477,501.49
汇率变动对现金及现金等价物的影响1,935,223.651,822,042.821,595,530.553,377,635.21
现金及现金等价物净增加额24,473,569.69277,344,905.18-38,593,129.39-247,403,383.28
期末现金及现金等价物余额117,006,412.85369,877,748.3453,939,713.7792,532,843.16
补充资料:
现金及现金等价物的净增加额-277,344,905.18--247,403,383.28
最新报告期:2025-08-23
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
方正证券许睿,周超泽0.310.470.652025-08-23
TOP↑